Dicerna Pharmaceuticals
Why Robinhood?
You can watch DRNA and buy or sell other stocks, ETFs, and their options commission-free!About DRNA
Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. It uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas.
DRNA Key Statistics
Stock Snapshot
Dicerna Pharmaceuticals(DRNA) stock is priced at $38.22, giving the company a market capitalization of 2.98B. It carries a P/E multiple of -23.44.
On 2026-05-31, Dicerna Pharmaceuticals(DRNA) stock opened at —, reached a high of —, and a low of —.
The Dicerna Pharmaceuticals(DRNA)'s current trading volume is 0, compared to an average daily volume of 3.2M.
During the past year, Dicerna Pharmaceuticals(DRNA) stock moved between $19.06 at its lowest and $40.14 at its peak.
During the past year, Dicerna Pharmaceuticals(DRNA) stock moved between $19.06 at its lowest and $40.14 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.